av/astrazeneca--big.svg

NASDAQ:AZN

AstraZeneca plc

  • Stock

USD

Last Close

12,060.00

26/07 15:49

Market Cap

1.88B

Beta: 0.17

Volume Today

1.50M

Avg: 4.68M

PE Ratio

34.25

PFCF: 28.96

Dividend Yield

2.22%

Payout:75.97%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.99B
-
1.93B
2.54%
2.05B
6.05%
2.24B
9.12%
2.68B
19.92%
2.96B
10.36%
3.04B
2.67%
3.61B
18.64%
6.50B
80.23%
6.84B
5.19%
5.06B
26.01%
average payables
9.79B
-
11.12B
13.61%
11.77B
5.85%
11.07B
5.95%
11.06B
0.10%
12.24B
10.64%
13.41B
9.58%
14.89B
10.97%
17.36B
16.63%
18.99B
9.37%
11.15B
41.26%
average receivables
-59.50M
-
-116.50M
95.80%
-112M
3.86%
-100.50M
10.27%
-92M
8.46%
-109.50M
19.02%
-63M
42.47%
5.38B
-
5.38B
0%
3.61B
32.96%
book value per share
18.55
-
15.55
16.16%
14.63
5.94%
11.74
19.73%
11.82
0.63%
9.84
16.72%
10.09
2.53%
11.91
18.01%
27.69
132.57%
23.93
13.60%
25.06
4.74%
capex per share
-1.64
-
-2.18
32.66%
-2.21
1.15%
-1.83
17.07%
-1.28
30.05%
-1.08
15.44%
-1.89
74.74%
-1.99
5.05%
-1.55
21.89%
-1.66
7.05%
-2.42
45.63%
capex to depreciation
-0.45
-
-0.84
86.73%
-0.98
16.58%
-0.98
0.43%
-0.53
45.65%
-0.37
31.54%
-0.65
79.00%
-0.83
26.56%
-0.34
59.29%
-0.47
39.26%
-0.77
63.21%
capex to operating cash flow
-0.28
-
-0.39
40.20%
-0.84
115.11%
-0.56
33.44%
-0.45
18.90%
-0.52
15.66%
-0.83
58.22%
-0.54
34.46%
-0.37
32.06%
-0.26
28.95%
-0.37
39.32%
capex to revenue
-0.08
-
-0.11
31.75%
-0.11
7.00%
-0.10
10.85%
-0.07
28.32%
-0.06
13.93%
-0.10
62.55%
-0.10
2.95%
-0.06
39.95%
-0.06
1.41%
-0.08
42.26%
cash per share
8.00
-
5.67
29.11%
5.42
4.37%
4.67
13.95%
3.60
22.90%
4.48
24.63%
4.78
6.61%
6.09
27.45%
4.51
25.93%
4.14
8.30%
3.75
9.33%
days of inventory on hand
132.44
-
122.46
7.54%
168.36
37.48%
206.47
22.64%
256.55
24.25%
213.71
16.70%
236.83
10.82%
277.18
17.04%
263.63
4.89%
138.42
47.50%
239.45
72.99%
days payables outstanding
718.90
-
742.62
3.30%
916.27
23.38%
927.63
1.24%
984.01
6.08%
949.55
3.50%
1.04K
9.26%
1.09K
4.80%
555.79
48.88%
560.86
0.91%
144.23
74.28%
days sales outstanding
-1.69
-
-1.59
5.61%
-1.62
1.91%
-1.44
11.14%
-1.51
4.64%
-2.08
37.78%
104.94
-
debt to assets
0.19
-
0.19
0.31%
0.25
35.30%
0.27
7.37%
0.28
4.56%
0.32
12.12%
0.30
5.76%
0.31
2.84%
0.29
4.35%
0.30
3.71%
0.28
6.58%
debt to equity
0.45
-
0.55
23.65%
0.81
47.36%
1.13
38.99%
1.19
5.19%
1.53
28.79%
1.39
9.42%
1.30
6.05%
0.78
39.91%
0.79
0.69%
0.73
7.35%
dividend yield
0.05
-
0.04
15.49%
0.04
2.31%
0.05
28.06%
0.04
22.44%
0.04
7.88%
0.03
24.96%
0.03
1.47%
0.02
14.88%
0.02
10.54%
0.02
2.38%
earnings yield
0.03
-
0.01
59.93%
0.03
136.76%
0.05
55.27%
0.03
32.69%
0.02
33.18%
0.01
54.91%
0.02
137.20%
0.00
97.24%
0.02
2,220.70%
0.03
80.58%
enterprise value
75.39B
-
93.84B
24.48%
95.29B
1.54%
80.77B
15.24%
102.37B
26.75%
108.74B
6.22%
142.63B
31.17%
143.53B
0.63%
190.55B
32.77%
233.19B
22.37%
233.52B
0.14%
enterprise value over ebitda
9.03
-
17.09
89.18%
13.62
20.30%
11.07
18.69%
15.12
36.52%
15.18
0.38%
20.33
33.96%
17.15
15.66%
25.19
46.91%
25.00
0.74%
16.79
32.86%
ev to operating cash flow
10.19
-
13.30
30.51%
28.67
115.60%
19.49
32.03%
28.61
46.83%
41.53
45.17%
48.04
15.67%
29.91
37.75%
31.96
6.85%
23.78
25.60%
22.57
5.06%
ev to sales
2.93
-
3.60
22.65%
3.86
7.24%
3.51
8.95%
4.56
29.78%
4.92
8.02%
5.85
18.83%
5.39
7.82%
5.09
5.55%
5.26
3.24%
5.10
3.05%
free cash flow per share
4.27
-
3.41
20.03%
0.42
87.57%
1.45
241.33%
1.55
6.85%
0.98
36.36%
0.39
60.25%
1.67
327.23%
2.65
58.76%
4.68
76.17%
4.20
10.07%
free cash flow yield
0.07
-
0.05
33.04%
0.01
87.14%
0.03
328.25%
0.02
16.07%
0.01
40.74%
0.00
70.29%
0.02
326.89%
0.02
35.31%
0.03
52.03%
0.03
9.52%
graham net net
-17.39
-
-24.48
40.83%
-26.72
9.13%
-30.72
14.96%
-32.16
4.69%
-31.24
2.86%
-29.95
4.11%
-31.32
4.56%
-33.23
6.11%
-32.73
1.49%
-34.17
4.41%
graham number
29.19
-
18.49
36.66%
27.12
46.68%
27.03
0.33%
25.10
7.13%
19.41
22.70%
15.26
21.35%
25.55
67.38%
7.02
72.54%
33.81
382.02%
46.36
37.11%
income quality
2.27
-
5.66
150.08%
1.08
80.88%
1.17
7.74%
1.61
37.68%
1.31
18.24%
1.92
46.01%
1.23
36.10%
-22.50
1,936.16%
3.92
117.43%
1.50
61.76%
intangibles to total assets
0.47
-
0.56
19.23%
0.57
3.40%
0.63
9.34%
0.60
4.40%
0.56
7.49%
0.53
4.60%
0.49
7.20%
0.59
20.48%
0.61
3.50%
0.57
6.18%
interest coverage
7.50
-
2.22
70.41%
3.83
72.46%
3.54
7.45%
2.44
31.16%
2.39
2.11%
2.04
14.45%
3.95
93.57%
0.81
79.45%
2.79
243.62%
5.16
84.72%
interest debt per share
8.68
-
9.35
7.74%
12.76
36.39%
14.38
12.71%
15.26
6.09%
16.21
6.22%
15.11
6.75%
16.53
9.39%
22.62
36.88%
19.75
12.69%
19.34
2.09%
inventory turnover
2.76
-
2.98
8.15%
2.17
27.26%
1.77
18.46%
1.42
19.52%
1.71
20.05%
1.54
9.76%
1.32
14.56%
1.38
5.14%
2.64
90.46%
1.52
42.19%
invested capital
0.45
-
0.55
23.65%
0.81
47.36%
1.13
38.99%
1.19
5.19%
1.53
28.79%
1.39
9.42%
1.30
6.05%
0.78
39.91%
0.79
0.69%
0.73
7.35%
market cap
74.23B
-
89.36B
20.38%
86.47B
3.23%
68.98B
20.23%
87.89B
27.42%
94.45B
7.47%
129.78B
37.40%
130.98B
0.93%
166.10B
26.82%
210.12B
26.50%
210.74B
0.29%
net current asset value
-12.31B
-
-22.25B
80.75%
-25.61B
15.08%
-32.59B
27.28%
-33.56B
2.97%
-31.02B
7.59%
-31.22B
0.65%
-31.55B
1.05%
-39.83B
26.26%
-36.83B
7.53%
-36.90B
0.18%
net debt to ebitda
0.14
-
0.82
487.84%
1.26
54.30%
1.62
28.33%
2.14
32.31%
1.99
6.81%
1.83
8.06%
1.50
18.21%
3.23
115.63%
2.47
23.49%
1.64
33.78%
net income per share
2.04
-
0.98
52.14%
2.23
128.75%
2.77
23.76%
2.37
14.30%
1.70
28.25%
1.03
39.67%
2.44
137.39%
0.08
96.76%
2.12
2,589.17%
3.81
79.49%
operating cash flow per share
5.91
-
5.59
5.38%
2.63
52.98%
3.28
24.60%
2.83
13.75%
2.07
26.89%
2.28
10.44%
3.66
60.28%
4.21
14.97%
6.34
50.67%
6.62
4.53%
payables turnover
0.51
-
0.49
3.19%
0.40
18.95%
0.39
1.22%
0.37
5.73%
0.38
3.63%
0.35
8.47%
0.34
4.58%
0.66
95.63%
0.65
0.90%
2.53
288.88%
receivables turnover
-216.06
-
-228.90
5.94%
-224.62
1.87%
-252.77
12.53%
-241.56
4.43%
-175.32
27.42%
3.48
-
research and ddevelopement to revenue
0.19
-
0.21
14.02%
0.24
13.53%
0.26
5.50%
0.26
0.08%
0.27
4.79%
0.24
9.01%
0.23
7.88%
0.26
15.60%
0.22
15.41%
0.24
8.45%
return on tangible assets
0.09
-
0.05
44.71%
0.11
133.18%
0.15
36.24%
0.12
21.20%
0.08
32.57%
0.05
42.11%
0.09
103.70%
0.00
97.23%
0.09
3,277.61%
0.14
57.41%
revenue per share
20.54
-
20.68
0.69%
19.55
5.47%
18.18
6.98%
17.74
2.41%
17.43
1.75%
18.74
7.50%
20.29
8.24%
26.39
30.07%
28.65
8.58%
29.33
2.37%
roe
0.11
-
0.06
42.92%
0.15
143.20%
0.24
54.18%
0.20
14.84%
0.17
13.84%
0.10
41.16%
0.20
101.17%
0.00
98.61%
0.09
3,012.55%
0.15
71.37%
roic
0.09
-
0.07
20.08%
0.11
62.58%
0.15
31.44%
0.14
2.38%
0.11
23.65%
0.07
34.40%
0.11
56.13%
-0.01
105.71%
0.07
1,240.70%
0.10
39.63%
sales general and administrative to revenue
0.47
-
0.50
4.94%
0.45
9.72%
0.41
9.01%
0.46
11.31%
shareholders equity per share
18.55
-
15.55
16.16%
14.63
5.94%
11.74
19.73%
11.82
0.63%
9.84
16.72%
10.09
2.53%
11.91
18.01%
27.69
132.57%
23.93
13.60%
25.06
4.74%
stock based compensation to revenue
tangible asset value
-2.77B
-
-12.88B
364.32%
-16.00B
24.21%
-22.57B
41.05%
-21.37B
5.33%
-19.62B
8.18%
-17.91B
8.75%
-17.15B
4.19%
-23.10B
34.64%
-22.07B
4.45%
-18.97B
14.04%
tangible book value per share
-2.22
-
-10.21
360.65%
-12.66
24.02%
-17.85
40.94%
-16.88
5.41%
-15.49
8.26%
-13.76
11.14%
-13.07
5.00%
-16.29
24.58%
-14.26
12.47%
-12.15
14.81%
working capital
4.28B
-
-633M
114.78%
1.14B
279.78%
-1.99B
275.22%
-3.23B
62.14%
-701M
78.32%
-2.55B
264.34%
-763M
70.13%
3.65B
578.37%
-3.70B
201.37%
-5.49B
48.32%

All numbers in USD (except ratios and percentages)